Issue 28
Get instant access to latest e-book

latest newsRead more...

22

Nov 2017

Perrigo Company Completes Divestiture Of API Business For $110 Million

Perrigo Company plc announced that it has completed the previously announced divestiture of its Active Pharmaceutical Ingredient API business based in Israel to SK Capital for million Perrigos CEO John T Hendrickson stated Todays announcement furthers the strategic review process announced when I became CEO…

22

Nov 2017

Fresenius Kabi to Expand Pharmaceutical Manufacturing in North Carolina

Fresenius Kabi a global health care company that specializes in medicines and technologies for infusion transfusion and clinical nutrition will expand its manufacturing operations in Wilson County Governor Roy Cooper announced today The expansion project will bring hundreds of new jobs and more than million…

21

Nov 2017

BiondVax and NIH Sign Clinical Trial Agreement for a Phase 2 Trial in the U.S. with BiondVax's Universal Flu Vaccine

BiondVax Pharmaceuticals Ltd announced the signing of the clinical trial agreement CTA for a Phase clinical trial with the National Institute of Allergy and Infectious Diseases NIAID of the US National Institutes of Health NIH The study is titled A Phase II DoubleBlind Multicenter Randomized…

press releasesRead more...

22

Nov 2017

Father gives a New Lease of Life to his Son at Continental Hospitals

Business Wire IndiaContinental Hospitals Fanconis AnemiaA Haploidentical Stem Cell Transplant was successfully performed on a yearold male child suffering from a rare blood disorder called Fanconis Anemia The incidence of…

22

Nov 2017

Palatin Technologies Announces Signing of Licensing Agreement with Kwangdong Pharmaceutical for Republic of Korea

Palatin Technologies Inc announced that it has entered into a collaboration and license agreement with Kwangdong Pharmaceutical Co Ltd Kwangdong for exclusive rights to develop and commercialize bremelanotide for female…

22

Nov 2017

Sumitomo Dainippon Pharma and Angelini Announce Partnership for Commercialization of Latuda® (Lurasidone Hydrochloride) in Europe

Sumitomo Dainippon Pharma Co Ltd and Angelini SpA announced that the companies have formed a partnership entering into a license and distribution agreement with the goal to expand availability in…

EventsRead more...

21-24

Nov 2017

Pharmtech & Ingredients

ITE Moscow
Crocus Expo IEC

27-28

Nov 2017

20th Annual Meeting on Neurology and Neurosurgery

conference series LLC
JW Marriott Dubai

TOP ARTICLES

  • 4

    Parenteral Preparations

    INTRODUCTION Parenteral preparations are defined as solutions suspensionsemulsions for injection or infusion powders for injection or infusion gels for injecti..

Knowledge Bank

  • Interviews

    Datwyler Pharma Packaging

    Senior Manager Global Scientific Affairs
    Renaud Janssen PhD is the Senior Manager of Global Scientific Affairs at Datwyler Pharma Packaging He frequently presents on international conferences on subjects related to elastomeric and aluminiumplastic closures for pharmaceutical applications Re..

  • Articles

    Mesoporous Silica Nanoparticles

    Mesoporous Silica Nanoparticles MSNs have attracted great attention over the last decade as a drug delivery system in the fields of biotechnology and Nano medicine due to their unique and adjustable physiochemical properties MSNs were first synthesised by Mobil researchers in and were called Mobil Crystalline Materials MCM Some years later the research group…

  • Techno Trends

    Sanofi and Regeneron’s Cemiplimab Receives FDA "Breakthrough Designation"

    Sanofi and Regeneron announced that Cemiplimab REGN has received FDA Breakthrough Therapy Designation for Advanced Cutaneous Squamous Cell Carcinoma Cemiplimab is an investigational human monoclonal antibody targeting PD It would be used to treat adults with metastatic cutaneous squamous cell carcinoma CSCC and adults with locally advanced and unresectable CSCC the second deadliest skin cancer after melanoma Preliminary results for…

Editorial Section

  • Strategy

    China Biopharma

    China today according to our recent studies is actively growing its domestic industry not only to support its huge domestic demand for high quality therapeutics but also to develop an export market capability The industry is making progress with substantial…

  • Clinical Trials

    Patient Recruitment

    To address the challenges faced in patient recruitment and retention in clinical trials innovative technologies are being utilised in AsiaPacific as well as other regions to optimise the processes involved From patient matching to improving the consent process technology has…

  • Manufacturing

    Continuous Manufacturing

    The urgent need to dramatically improve efficiency and productivity within the pharmaceutical manufacturing sector is in the state of flux With the US FDAs push for moving the pharmaceutical industry into st century reality of…

  • Expert Talk

    The Asian Healthcare Market

    The Asian market is growing rapidly and along with this expansion comes the issue of drug counterfeiting Bernd offers his insight into the key trends affecting this market and what regulatory authorities are expecting manufacturers…

TOP